Citation Impact
Citing Papers
MHC-Restricted Cytotoxic T Cells: Studies on the Biological Role of Polymorphic Major Transplantation Antigens Determining T-Cell Restriction-Specificity, Function, and Responsiveness
1979 StandoutNobel
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
2021 StandoutNobel
Liver macrophages in murine listeriosis. Cell-mediated immunity is correlated with an influx of macrophages capable of generating reactive oxygen intermediates.
1985 StandoutNobel
Engineering adeno-associated viruses for clinical gene therapy
2014
Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid
2016 StandoutNobel
Impaired immune and acute-phase responses in interleukin-6-deficient mice
1994 StandoutNatureNobel
Liver-specific microRNA-122 target sequences incorporated in AAV vectors efficiently inhibits transgene expression in the liver
2010
Innate Immune Responses to AAV Vectors
2011
AAV Capsid Structure and Cell Interactions
2011
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Tropism-modified AAV Vectors Overcome Barriers to Successful Cutaneous Therapy
2014
Efficient and Targeted Transduction of Nonhuman Primate Liver With Systemically Delivered Optimized AAV3B Vectors
2015
Intracellular transport of recombinant adeno-associated virus vectors
2012
Regulatory T Cells
2000 StandoutNobel
Superantigen Shock In Mice With An Inapparent Viral Infection
1994 StandoutNobel
State-of-the-art gene-based therapies: the road ahead
2011
Unique Roles of TLR9- and MyD88-Dependent and -Independent Pathways in Adaptive Immune Responses to AAV-Mediated Gene Transfer
2015
Delivery technologies for cancer immunotherapy
2019 Standout
Optimal Immunofluorescent Staining for Human Factor IX and Infiltrating T Cells following Gene Therapy for Hemophilia B
2013
Non-viral vectors for gene-based therapy
2014 Standout
Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
2018
Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies
2016
Vector Design Tour de Force: Integrating Combinatorial and Rational Approaches to Derive Novel Adeno-associated Virus Variants
2014
In vivo genome editing using Staphylococcus aureus Cas9
2015 StandoutNature
Gene therapy for hemophilia
2015
Adeno-associated virus (AAV) vectors in cancer gene therapy
2016
The potential of adeno-associated viral vectors for gene delivery to muscle tissue
2014
The AAV Vector Toolkit: Poised at the Clinical Crossroads
2012
Non-coding RNAs in human disease
2011 Standout
Adeno-associated virus vector as a platform for gene therapy delivery
2019 Standout
Novel Adeno-associated Viruses Derived From Pig Tissues Transduce Most Major Organs in Mice
2014
Development of gene transfer for induction of antigen-specific tolerance
2014
Optimization of the Capsid of Recombinant Adeno-Associated Virus 2 (AAV2) Vectors: The Final Threshold?
2013
Antigen-presenting cell function in the tolerogenic liver environment
2010
Progress and prospects: immune responses to viral vectors
2009
Emerging Issues in AAV-Mediated In Vivo Gene Therapy
2017
TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional Properties
1989 Standout
Role of the vector genome and underlying factor IX mutation in immune responses to AAV gene therapy for hemophilia B
2014
Efficacy and Safety of Long-term Prophylaxis in Severe Hemophilia A Dogs Following Liver Gene Therapy Using AAV Vectors
2010
State of play and clinical prospects of antibody gene transfer
2017
Human Hepatocyte Growth Factor Receptor Is a Cellular Coreceptor for Adeno-Associated Virus Serotype 3
2010
Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial
2017
Selective In Vivo Targeting of Human Liver Tumors by Optimized AAV3 Vectors in a Murine Xenograft Model
2014
Adeno-Associated Virus at 50: A Golden Anniversary of Discovery, Research, and Gene Therapy Success—A Personal Perspective
2015
Adeno-Associated Virus Gene Therapy for Liver Disease
2016
Prolonged Gene Expression in Muscle Is Achieved Without Active Immune Tolerance Using MicrorRNA 142.3p-Regulated rAAV Gene Transfer
2013
Sequences related to immunoglobulin kappa chain messenger RNA in T cells.
1976 StandoutNobel
T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views.
1980 Standout
Specificity, Ly phenotype, and H-2 compatibility requirements of effector cells in delayed-type hypersensitivity responses to murine influenza virus infection.
1980
The Relationship Between Humoral and Cell‐Mediated Immunity
1972
Induction of cytokines in mice with parainfluenza pneumonia
1995 StandoutNobel
Roles of protein and carbohydrate in glycoprotein processing and secretion. Studies using mutants expressing altered IgM mu chains.
1981 StandoutNobel
Naturally Arising CD4+Regulatory T Cells for Immunologic Self -Tolerance and Negative Control of Immune Responses
2003 StandoutNobel
Delayed Hypersensitivity in the Mouse
1975
Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer.
1982 StandoutNobel
Thymus and autoimmunity: capacity of the normal thymus to produce pathogenic self-reactive T cells and conditions required for their induction of autoimmune disease.
1990 StandoutNobel
Expression of T-cell differentiation antigens on effector cells in cell-mediated cytotoxicity in vitro. Evidence for functional heterogeneity related to the surface phenotype of T cells.
1975
CYTOTOXIC THYMUS-DERIVED LYMPHOCYTES IN CEREBROSPINAL FLUID OF MICE WITH LYMPHOCYTIC CHORIOMENINGITIS
1973 StandoutNobel
Infectious Molecular Clones of Adeno-Associated Virus Isolated Directly from Human Tissues
2008
Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.
1989 Standout
Analysis of Autoimmunity through Experimental Models of Thyroiditis and Allergic Encephalomyelitis
1980
T Cell Response to Viral and Bacterial Infection
1974
H-2 compatibility requirement for virus-specific T-cell-mediated cytolysis. Evaluation of the role of H-2I region and non-H-2 genes in regulating immune response.
1976 StandoutNobel
The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9–dependent innate immune responses in the liver
2011
Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. VI. Evidence for different T cell receptors in cells that mediate H-21-restricted and H-2D-restricted cutaneous sensitivity responses.
1980 StandoutNobel
Functional Specificity of Thymus-Dependent Lymphocytes
1977 StandoutScienceNobel
Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease.
1985 StandoutNobel
Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor
1975 StandoutNobel
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
2023 StandoutNobel
Novel Proteinaceous Infectious Particles Cause Scrapie
1982 StandoutScienceNobel
Adeno-Associated Virus Structural Biology as a Tool in Vector Development
2013
Independence of θ and TL surface antigens and killing by thymidine, cortisol, phytohemagglutinin, and cyclic AMP in a murine lymphoma
1973
Capacity of influenza virus-monoclonal antibody mixtures to stimulate memory and cytotoxic T lymphocyte populations
1982 StandoutNobel
Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells
2013
Treatment of mice with polyinosinic-polycytidilic polyribonucleotide reduces T-cell involvement in a localized inflammatory response to vaccinia virus challenge
1985 StandoutNobel
Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis.
1982 StandoutNobel
Immune responses to AAV vectors: overcoming barriers to successful gene therapy
2013
Suppression of cell-mediated immunity by street rabies virus.
1977 StandoutNobel
Phenotypic analysis of the inflammatory exudate in murine lymphocytic choriomeningitis.
1987 StandoutNobel
H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;.
1975 StandoutNobel
Membrane Immunoglobulins and Antigen Receptors on B and T Lymphocytes
1974
Of Mice and Not Men: Differences between Mouse and Human Immunology
2004 Standout
Immunology of Autoimmune Thyroid Diseases
1982 Standout
Viral Vectors for Gene Therapy: Translational and Clinical Outlook
2015
In vitro evidence of cell-mediated immunity after exposure of mice to both live and inactivated rabies virus.
1977 StandoutNobel
Binding of solubilized human TSH-receptor protein by peripheral blood lymphocytes of patients with Graves’ disease
1981
H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus.
1975 StandoutNobel
H9/25 monoclonal antibody recognizes a new allospecificity of mouse lymphocyte subpopulations: Strain and tissue distribution
1980 StandoutNobel
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery
2017 StandoutNobel
Characterization of Human Antiviral Adaptive Immune Responses during Hepatotropic Virus Infection in HLA-Transgenic Human Immune System Mice
2013 StandoutNobel
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
Frequency of precursor cells against the enzyme β‐galactosidase An estimate of the BALB/c strain antibody repertoire
1976 StandoutNobel
Tolerance, the thymus, and suppressor T cells.
1977
Thymus and Autoimmunity: Production of CD25+CD4+ Naturally Anergic and Suppressive T Cells as a Key Function of the Thymus in Maintaining Immunologic Self-Tolerance
1999 StandoutNobel
Protection against lethal lymphocytic choriomeningitis virus (LCMV) infection by immunization of mice with an influenza virus containing an LCMV epitope recognized by cytotoxic T lymphocytes
1994 StandoutNobel
T‐Cell‐Mediated Immunopathology in Viral Infections
1974 StandoutNobel
Cell‐Mediated Immunity to Bacterial Infection in the Mouse. Thymus‐Derived Cells as Effectors of Acquired Resistance to Listeria monocytogenes
1972
Specificity of Virus‐Immune Effector T Cells for H‐2K or H‐2D Compatible Interactions: Implications for H‐Antigen Diversity
1976 StandoutNobel
Works of Mario Cooper being referenced
Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses
2008
Tolerance Induction to Cytoplasmic β-Galactosidase by Hepatic AAV Gene Transfer — Implications for Antigen Presentation and Immunotoxicity
2009
Impact of the Underlying Mutation and the Route of Vector Administration on Immune Responses to Factor IX in Gene Therapy for Hemophilia B
2009
Improved Induction of Immune Tolerance to Factor IX by Hepatic AAV-8 Gene Transfer
2009
Delayed‐Type Hypersensitivity in the Mouse
1972
Delayed‐Type Hypersensitivity in the Mouse
1972
THE IN VIVO LOCALIZATION PATTERNS AND THE IN VITRO BINDING TO LYMPHOCYTES OF NORMAL AND TOLERANT RATS BY SALMONELLA FLAGELLIN AND ITS DERIVATIVES
1971
Delayed‐Type Hypersensitivity in the Mouse
1972
The incidence of hemocyanin-binding cells in hemocyanin-tolerant rats
1972